Uveal Malignant Melanoma: Management Options - Proton Beam Radiotherapy

Clinical Ophthalmic Oncology

Volumn , Issue , 2007, Pages 248-253

  Lane, Anne Marie ^a   Gragoudas, Evangelos S ^b  

^a Retina Research Unit   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 45249117912     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-3167-3.50047-4     Document Type: Chapter

References (45)

1. Damato B, Groenewald C, McGalliard J, Wong D Endoresection of choroidal melanoma. Br J Ophthalmol 1998, 82:213-218.
2. Damato B, Groenewald CP, McGalliard JN, Wong D Rhegmatogenous retinal detachment after transscleral local resection of choroidal melanoma. Ophthalmology 2002, 109:2137-2143.
3. Harbour JW, Meredith TA, Thompson PA, Gordon ME Transpupillary thermotherapy versus plaque radiotherapy for suspected choroidal melanomas. Ophthalmology 2003, 110:2207-2214.
4. Damato B, Jones AG Uveal melanoma: resection techniques. Ophthalmol Clin North Am 2005, 18:119-128.
5. Char DH, Miller T, Crawford JB Uveal tumour resection. Br J Ophthalmol 2001, 85:1213-1219.
6. Bartlema YM, Oosterhuis JA, Journee-De Korver JG, Tjho-Heslinga RE, Keunen JE Combined plaque radiotherapy and transpupillary thermotherapy in choroidal melanoma: 5 years' experience. Br J Ophthalmol 2003, 87:1370-1373.
7. Nag S, Quivey JM, Earle JD, Followill D The American Brachytherapy Society recommendations for brachytherapy of uveal melanomas. Int J Radiat Oncol Biol Phys 2003, 56:544-555.
8. Gragoudas E, Li W, Goitein M, Lane AM, Munzenrider JE, Egan KM Evidence-based estimates of outcome in patients irradiated for intraocular melanoma. Arch Ophthalmol 2002, 120:1665-1671.
9. Char DH, Kroll SM, Castro J Ten-year follow-up of helium ion therapy for uveal melanoma. Am J Ophthalmol 1998, 125:81-89.
10. Seddon JM, Gragoudas ES, Egan KM, et al. Relative survival rates after alternative therapies for uveal melanoma. Ophthalmology 1990, 97:769-777.
11. Puusaari I, Heikkonen J, Summanen P, Tarkkanen A, Kivelä T Iodine brachytherapy as an alternative to enucleation for large uveal melanomas. Ophthalmology 2003, 110:2223-2234.
12. Diener-West M, Earle JD, Fine SL, et al. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, III: initial mortality findings. COMS Report No. 18. Arch Ophthalmol 2001, 119:969-982.
13. Mueller AJ, Talies S, Schaller UC, et al. Stereotactic radiosurgery of large uveal melanomas with the gamma knife. Ophthalmology 2000, 107:1381-1387. discussion 87-88.
14. Haas A, Pinter O, Papaefthymiou G, et al. Incidence of radiation retinopathy after high-dosage single-fraction gamma knife radiosurgery for choroidal melanoma. Ophthalmology 2002, 109:909-913.
15. Suit H The Gray Lecture 2001: Coming technological advances in radiation oncology. Int J Radiat Oncol Biol Phys 2002, 53:798-809.
16. Suit HD, Gotein M, Tepper J, et al. Exploratory study of proton radiation therapy using large field techniques and fractionated dose schedules. Cancer 1975, 35:1646-1657.
17. Koehler A, Schneider R, Sisterson J Range modulators for protons and heavy ions. Nucl Instrum Meth 1975, 131:437-440.
18. Gragoudas E, Goitein M, Koehler A, et al. Proton irradiation of choroidal melanomas: Preliminary results. Arch Ophthalmol 1978, 96:1583-1591.
19. Goitein M, Miller T Planning proton therapy of the eye. Med Phys 1983, 10:275-283.
20. Egger E, Schalenbourg A, Zografos L, et al. Maximizing local tumor control and survival after proton beam radiotherapy of uveal melanoma. Int J Radiat Oncol Biol Phys 2001, 51:138-147.
21. Egger E, Zografos L, Schalenbourg A, et al. Eye retention after proton beam radiotherapy for uveal melanoma. Int J Radiat Oncol Biol Phys 2003, 55:867-880.
22. Damato B, Kacperek A, Chopra M, Campbell IR, Errington RD Proton radiotherapy of choroidal melanoma: The Liverpool-Clatterbridge experience. Int J Rad Oncol Biol Phys 2005, 62:1405-1411.
23. Courdi A, Caujolle JP, Grange JD, et al. Results of proton therapy of uveal melanomas treated in Nice. Int J Radiat Oncol Biol Phys 1999, 45:5-11.
24. Gragoudas ES, Lane AM, Munzenrider J, Egan KM, Li W Long-term risk of local failure after proton therapy for choroidal/ciliary body melanoma. Trans Am Ophthalmol Soc 2002, 100:43-48.
25. Kodjikian L, Roy P, Rouberol F, et al. Survival after proton-beam irradiation of uveal melanomas. Am J Ophthalmol 2004, 137:1002-1010.
26. Egan K, Ryan L, Gragoudas E Survival implications of enucleation after definitive radiotherapy for choroidal melanoma: An example of regression on time-dependent covariates. Arch Ophthalmol 1998, 116:366-370.
27. Fuss M, Loredo LN, Blacharski PA, Grove RI, Slater JD Proton radiation therapy for medium and large choroidal melanoma: preservation of the eye and its functionality. Int J Radiat Oncol Biol Phys 2001, 49:1053-1059.
28. Saornil M, Egan K, Gragoudas E, et al. Histopathology of proton beam-irradiated vs enucleated uveal melanomas. Arch Ophthalmol 1992, 110:1112-1118.
29. Regan S, Egan KM, Hart L, Gragoudas ES Color Doppler imaging of untreated and irradiated choroidal melanomas. Eur J Ophthalmol 2001, 11:150-155.
30. Seddon JM, Gragoudas ES, Polivogianis L, et al. Visual outcome after proton beam irradiation of uveal melanoma. Ophthalmology 1986, 93:666-674.
31. Seddon JM, Gragoudas ES, Egan KM, et al. Uveal melanomas near the optic disc or fovea. Visual results after proton beam irradiation. Ophthalmology 1987, 94:354-361.
32. Gragoudas ES, Li W, Lane AM, Munzenrider J, Egan KM Risk factors for radiation maculopathy and papillopathy after intraocular irradiation. Ophthalmology 1999, 106:1571-1578.
33. Foss AJ, Whelehan I, Hungerford JL, et al. Predictive factors for the development of rubeosis following proton beam radiotherapy for uveal melanoma. Br J Ophthalmol 1997, 81:748-754.
34. Gragoudas ES, Lane AM Uveal melanoma: proton beam irradiation. Ophthalmol Clin North Am 2005, 18:111-118.
35. Gragoudas ES, Egan KM, Walsh SM, et al. Lens changes after proton beam irradiation for uveal melanoma. Am J Ophthalmol 1995, 119:157-164.
36. Gragoudas ES, Lane AM, Regan S, et al. A randomized controlled trial of varying radiation doses in the treatment of choroidal melanoma. Arch Ophthalmol 2000, 118:773-778.
37. Desjardins L, Levy C, d'Hermies F, et al. Initial results of proton therapy in choroidal melanoma at the d'Orsey Center for Proton Therapy; the first 464 cases. Cancer Radiother 1997, 1:222-226.
38. Gragoudas E, Egan K, Seddon J, et al. Survival of patients with metastases from uveal melanoma. Ophthalmology 1991, 98:383-390.
39. Bedikian AY, Legha SS, Mavligit G, et al. Treatment of uveal melanoma metastatic to the liver: a review of the MD Anderson Cancer Center experience and prognostic factors. Cancer 1995, 76:1665-1670.
40. Eskelin S, Pyrhonen S, Hahka-Kemppinen M, Tuomaala S, Kivela T A prognostic model and staging for metastatic uveal melanoma. Cancer 2003, 97:465-475.
41. Flaherty LE, Unger JM, Liu PY, Mertens WC, Sondak VK Metastatic melanoma from intraocular primary tumors: the Southwest Oncology Group experience in phase II advanced melanoma clinical trials. Am J Clin Oncol 1998, 21:568-572.
42. Alexander HR, Libutti SK, Pingpank JF, et al. Hyperthermic isolated hepatic perfusion using melphalan for patients with ocular melanoma metastatic to liver. Clin Cancer Res 2003, 9:6343-6349.
43. Agarwala SS, Panikkar R, Kirkwood JM Phase I/II randomized trial of intrahepatic arterial infusion chemotherapy with cisplatin and chemoembolization with cisplatin and polyvinyl sponge in patients with ocular melanoma metastatic to the liver. Melanoma Res 2004, 14:217-222.
44. Aoyama T, Mastrangelo MJ, Berd D, et al. Protracted survival after resection of metastatic uveal melanoma. Cancer 2000, 89:1561-1568.
45. Hsueh EC, Essner R, Foshag LJ, et al. Prolonged survival after complete resection of metastases from intraocular melanoma. Cancer 2004, 100:122-129.